Azithromycin
Total 38 Posts
Azithromycin is a kind of аntibiotics. It can treat various types of infections, including pink eye (bacterial conjunctivitis).
Νέα έρευνα σε εξωτερικούς ασθενείς αποκαλύπτει ότι ο συνδυασμός Ψευδάργυρου, Υδροξυχλωροκινης, και αζιθρομυκίνης σχετίζεται με μειωμένες νοσηλείες και θανάτους σε ασθενείς με COVID-19
Η μελέτη αναφέρει ένα πολύ χαμηλό ποσοστό θνησιμότητας 0,71% σε ασθενείς που έλαβαν θεραπεία με επιβεβαιωμένα θετικά κρούσματα COVID-19.
Aimsíonn StaidéAR Othar Seachtrach Nua-Fhoilsithe Go Bhfuil Comhgléas Sinc, Hydroxychloroquine Agus Azithromycin Bainteach Le NíOS Lú Cur San Ospidéal Agus Báis in Othair COVID-19
Tuairiscíonn an staidéar ráta báis an-íseal de 0.71% in othair chóireáilte le cásanna dearfacha dearbhaithe de COVID-19.
Utafiti Mpya Uliochapishwa Hivi Karibuni Hugundua Kuwa Mchanganyiko WA Zinc, Hdroxychloroquine, NA Azithromycin Unahusishwa NA Hospitali NA Vifo Kidogo Katika Wagonjwa WA Covid-19
Utafiti unaripoti kiwango cha chini kabisa cha vifo vya asilimia 0.71% kwa wagonjwa waliotibiwa walio na kesi chanya za COVID-19.
Un Studiu îN Ambulatoriu Recent Publicat Arată Că O CombinațIe DE Zinc, Hidroxiclorochină șI Azitromicină Este Asociată CU O SCăDere a SpitalizăRilor șI Deceselor La PaciențII CU Covid-19
Studiul raportează o rată de fatalitate foarte scăzută de 0,71% la pacienții tratați cu cazuri pozitive confirmate de COVID-19.
Six More Studies Confirm That Early Treatment Using Dr. Zelenko’s Protocol Reduces Mortality Rates of COVID-19 Patients
All six studies showed that HCQ, given early in the course of the COVID-19 disease, alone or in combination with zinc and azithromycin, reduced hospital admissions and mortality without serious heart problems or other adverse effects.
신규 발표된 외래환자 연구결과에서 아연, 하이드록시클로로퀸과 아지트로마이신의 조합이 COVID-19 환자에서 입원율 및 사망율의 감소와 관련이 있음을 발견
이 연구는 COVID-19의 양성 사례가 확인 된 치료 환자에서 0.71 %의 매우 낮은 사망률을보고합니다.
Nuutgepubliseerde Buite-Pasiënt Studie Bevind dat die Kombinasie van Sink, Hydroxychloroquine en Azithromycin Direk Gekoppel is aan Minder Hospitaalopnames en Sterftes in COVID-19-Pasiënte
Die studie rapporteer 'n baie lae sterftesyfer van 0,71% in behandelde pasiënte met bevestigde positiewe gevalle van COVID-19.
